Vetticaden Santosh 4
4 · DEPOMED INC · Filed Oct 18, 2017
Insider Transaction Report
Form 4
DEPOMED INCDEPO
Vetticaden Santosh
SVP, Chief Medical Officer ***
Transactions
- Award
Stock Options
2017-10-16+109,343→ 109,343 totalExercise: $5.06Exp: 2027-10-16→ Common Stock (109,343 underlying) - Award
Restricted Stock Units
2017-10-16+53,325→ 53,325 total→ Common Stock (53,325 underlying)
Footnotes (3)
- [F1]Exercisable with respect to 25% of the underlying shares on October 16, 2018, and in 36 equal monthly installments thereafter, such that the stock options will be fully vested and exercisable on October 16, 2021.
- [F2]Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit.
- [F3]These restricted stock units are scheduled to vest 25% on October 16, 2018, 25% on October 16, 2019, 25% on October 16, 2020 and 25% on October 16, 2021, assuming continued employment through the applicable vesting date.